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ABSTRACT 
Bacteremia related to urinary tract infections (UTI) is associated with significant levels of morbidity 
and mortality as well as extensive financial costs for hospitals. Enterococcus faecalis accounts for 
the majority of enterococcal bacteremias with urinary tract infections reported as a frequent point of 
infection.  
In Denmark, the incidence of bacteremia due to E. faecalis has been rising notably for the last 
decades. However, no previous studies have investigated risk factors for the development of UTI-
related bacteremia specifically due to E. faecalis. 
In a retrospective case control study, I compared 51 patients, with UTI-related bacteremia due to E. 
faecalis, to 56 patients, with urinary tract infections due to E. faecalis but without bacteremia, to 
evaluate the role of different epidemiological characteristics and hospital procedures as potential 
risk factors for UTI-related bacteremia due to E. faecalis. 
This study shows that men undergoing urological surgery or catheterization have an increased risk 
of UTI-related bacteremia due to E. faecalis. Antibiotic prophylaxis that covers enterococci prior to 
urological surgery and catheterization might be a way to lower the risk of UTI-related bacteremia 
due to E. faecalis.   
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ABSTRACT - DANISH 
Blodforgiftninger, der er relateret til urinvejsinfektioner, medfører høj morbiditet, mortalitet samt 
betragtelige økonomiske omkostninger for hospitaler. Enterococcus faecalis er skyld i størstedelen 
af enterokok-blodforgiftninger og disse er ofte relateret til urinvejsinfektioner. 
I Danmark er forekomsten af enterokok-blodforgiftninger steget markant gennem de sidste årtier. 
På trods af det voksende antal blodforgiftninger, har ingen studier tidligere undersøgt risikofaktorer 
for urinvejsinfektionsrelaterede blodforgiftninger forårsaget af netop E. faecalis. I dette studie 
sammenlignede jeg to grupper af patienter for at undersøge, hvorvidt forskellige epidemiologiske 
karakteristika og hospitalsprocedurer var risikofaktorer for udviklingen af 
urinvejsinfektionsrelaterede blodforgiftninger med E. faecalis.  
De to grupper bestod af henholdsvis 51 patienter med urinvejsinfektionsrelaterede blodforgiftninger 
med E. faecalis, og 56 patienter med urinvejsinfektioner med E. faecalis, men uden 
blodforgiftninger.  
Mit studie viser, at mandlige patienter, der får foretaget en urologisk operation eller kateterisering, 
har en forhøjet risiko for at udvikle urinvejsinfektionsrelaterede blodforgiftninger med E. faecalis.  
Profylaktisk behandling med antibiotika, der er virksomt mod enterokokker, inden kateterisering og 
urologiske operationer kan være én måde at nedsætte risikoen for at patienter udvikler 
urinvejsinfektionsrelaterede blodforgiftninger med E. faecalis.  
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1 INTRODUCTION 
During the last couple of decades Enterococcus species have become of increasing medical interest 
as human pathogens causing infections in many countries, including Denmark 1–3.  
Enterococcus spp. are rated as the second most common pathogen causing urinary tract infections 
(UTI) and the third most common cause of bacteremia with reports of Enterococcus faecalis 
accounting for up to 65%-90% of clinical Enterococcus spp. isolates for some laboratories 4,5.  
Bacteremia is overall a major source of morbidity and mortality. In the United States, Enterococcus 
spp. accounted for 9.4% of all nosocomial bacteremia from March 1995 to September 2002 in a 
study investigating 49 US hospitals 1. This ranks enterocci as the third leading cause of nosocomial 
bacteremia in the US with E. faecalis as the dominant enterococcal species accounting for 55.2% of 
the identified enterococcal isolates 1,6.  
In Denmark, surveillance data have demonstrated a significant rise in the incidence of infections 
from enterococci. From 2002 to 2009 the incidence of E. faecalis bacteremia increased by 51% 7. In 
a recent Danish study, Pinholt et al., found urinary tract infections to be the most frequent point of 
infection for enterococcal bacteremia.2 Thus, part of the observed increase in enterococcal 
bacteremia might be related to urinary tract infections. 
Today, Enterococcus spp. and in particular E. faecalis is recognized as important human pathogens 
due to enterococcal bacteremia causing high levels of morbidity and mortality as well as extensive 
economic costs for the healthcare system. Previous studies have investigated UTI-related 
bacteremia in general and enterococcal bacteremia but none have investigated UTI-related 
bacteremia due to E. faecalis specifically. The emergence of E. faecalis, emphasize the need for 
more knowledge about UTI-related bacteremia due to E. faecalis.  
1.1 AIM 
The aim of this retrospective Danish population-based case-control study is to investigate a number 
of potential risk factors for UTI-related bacteremia due to E. faecalis. The variables investigated 
include quantity of E. faecalis in urine samples, epidemiologic characteristics of patients, 
catheterization (such as urinary catheters, nephrostomy or JJ-stents), urological surgery (such as 
cystoscopy, prostate or ureteral surgery) and surgery overall.  
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This study aims to generate knowledge that can help doctors to take proper precautions when 
treating patients at risk for UTI-related bacteremia due to E. faecalis. By evaluating epidemiologic 
and etiologic characteristics of E. faecalis specifically, the results of this study can be compared to 
characteristics of E. faecium to find possible differences between the two as well as differences 
compared to other bacteria that frequently infect the urinary tract and cause bacteremia.   
2 BACKGROUND 
In the following section, I will briefly describe the epidemiology, etiology and the medical burden 
of E. faecalis. 
2.1 TAXONOMY AND PREVALENCE 
Enterococci are gram-positive cocci that are commensal inhabitants of the human gastrointestinal 
tract and thus a part of the normal human fecal flora 8. Originally, enterococci were classified as 
group D streptococci but during the 1980’s genetic studies let to the conclusion that enterococci 
were sufficient diverse to be in a separate genus 9.  
Different studies have reported enterococci as the second most common pathogen causing urinary 
tract infections and the third most common cause of bacteremia. The enterococcal species of highest 
clinical and medical importance is E. faecalis accounting for up to 65%-90% of clinical isolates for 
most laboratories 2,4,5.  
2.2 MEDICAL BURDEN OF ENTEROCOCCUS FAECALIS 
E. faecalis is the enterococcus species causing most human infections. Among these human 
enterococcal infections, urinary tract infections are the most common, but also bacteremia, 
hepatobiliary sepsis, endocarditis, surgical wound infections and neonatal sepsis are commonly 
caused by Enterococcus spp. 3. Enterococci are accounting for approximately 12% of nosocomial 
infections in the US. Among these, E. faecalis is the most endemic in clinical infections. 5  
Bacteremia is overall a major source of morbidity and mortality and is reported as the 10th leading 
cause of death in the United States with an increase in age-adjusted death rate during the past two 
decades of 78%10. In the United States, Enterococcus spp. is reported to account for 9.4% of all 
nosocomial bacteremia from March 1995 to September 2002 in a study by Wisplinghoff et al.1 
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investigating 49 US hospitals. This ranks enterococci as the third leading cause of nosocomial 
bloodstream infections with E. faecalis as the dominant strain accounting for 55.2% of the 
identified enterococci isolates. 1,6  
In Denmark, surveillance data have demonstrated a significant rise in the incidence of enterococci. 
From 2002 to 2009 the incidence of E. faecalis bacteremia increased by 51% 7.  
The abovementioned data all contribute to E. faecalis now being recognized as an important human 
pathogen and a serious challenge to the healthcare system, with infective endocarditis following 
enterococcal bacteremia as the most severe type of infection due to the high levels of morbidity and 
mortality as well as the very expensive and long treatment. 
2.3 URINARY TRACT INFECTIONS 
Urinary tract infections are the most frequent healthcare-associated infection in the United 
States11,12 and the second most frequent in Denmark13. Notably, urinary tract infections have been 
reported as a frequent focus of infection for enterococcal bacteremia2,14. As described earlier, 
human infections by enterococci have increased notably through the past two to three decades and 
this increase includes a rise in cases of urinary tract infections. It is reasonable to suspect the 
increase in enterococcal urinary tract infections to be partly responsible for the increase in 
enterococcal bacteremia due to the association of the two. A number of previous studies 
investigating enterococcal bacteremia, all found urinary tract infections as one of the dominant 
sources of infection 14–16. 
Greene et al., 2012, investigated predictors of UTI-related bacteremia and found evidence that 
Enterococcus spp. (together with coagulase-positive staphylococcus) might have a greater tendency 
of spreading from the urinary tract to the bloodstream compared to other bacteria 17.  
The majority of urinary tract infections are related to indwelling urinary catheters 18. Notably, 
patients with indwelling urinary catheters have been reported to have a high incidence of 
enterococcal urinary tract infections compared to patients receiving outpatient treatment 19. 
2.4 BACTEREMIA DUE TO ENTEROCOCCUS FAECALIS 
UTI-related bacteremia occurs much less frequently compared to urinary tract infections but is in 
return associated with considerable human and economic costs due to high levels of morbidity and 
mortality and expensive treatment.  
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In the United States enterococci were reported as the third most common organism causing 
bacteremia with 9% of 24,179 cases1. In the case of UTI-related bacteremia, another study reports 
Enterococcus as the predominant causing bacteria in the US. 11 In the UK 7066 cases of 
Enterococcus bacteremia were reported in 2005 with 63% of these cases caused by E. faecalis 20. In 
Denmark, Pinholt et al., found that the overall incidence of enterococcal bacteremia for the period 
of 2006-2009 was dominated by E. faecalis.2 Overall, E. faecalis cause still more cases of 
bacteremia and urinary tract infections seem to be a frequent focus for these infections. 
2.4.1 Complication of infection: Infective endocarditis 
When circulating in the blood stream and passing the heart, E. faecalis is capable of adhering to the 
heart valves causing infective endocarditis. Thus, there is a risk for development of infective 
endocarditis in patients with bacteremia due to E. faecalis. Infective endocarditis is a frequent and 
severe complication of enterococcal bacteremia 9. Different studies suggest that enterococci are 
responsible for between 5 % and 20 % of all cases of infective endocarditis.21  Infective 
endocarditis is a severe infection with high mortality rates and a long and expensive treatment. 22 
2.4.2 Complication of treatment: Antibiotic resistance 
Enterococcal infections are difficult to treat as a result of frequent resistance in enterococci towards 
different antibiotics 23. Enterococcus spp. are intrinsic resistant towards cephalosporins. 
Furthermore, enterococci have frequently acquired resistance to glycopeptides, penicillins and 
aminoglycosides.24 
Enterococcal bacteremia in general is associated with mortality rates between 23% and 46% 25. 
Clinical outcomes are drastically influenced by antibiotic-resistant strains of enterococci with a 
reported increase in mortality from 27 % for antibiotic-susceptible strains to 52 % for strains 
resistant to glycopeptides.2  
The widespread antibiotic resistance of enterococci underlines the importance for a better 
understanding of the risk factors of UTI-related bacteremia due to E. faecalis in order to choose 
appropriate antibiotic prophylaxis for the patients at risk. Focused prophylaxis and treatment of 
enterococcal infections is critical to obtain effective treatment and to avoid creating a further 
selective pressure for resistant isolates of enterococci. 
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2.5 RISK FACTORS FOR UTI-RELATED BACTEREMIA & ENTEROCOCCAL BACTEREMIA 
Several studies through the last decades have investigated various risk factors for enterococcal 
bacteremia, UTI-related bacteremia as well as bacteremia in general.  
In 1929, W. W. Scott was the first to show that manipulation of the urinary tract often leads to 
bacteremia 26. Since then, many studies have confirmed the relation between manipulation of the 
urinary tract and bacteremia. In particular, urological surgery and catheterization are reported as 
frequent factors contributing to the risk of developing bacteremia 17,27. Due to the findings of these 
previous studies I chose to put special interest on catheterization and urological surgery as potential 
risk factors specifically for UTI-related bacteremia due to E. faecalis. 
3 METHODS AND MATERIALS 
3.1 SETTING 
This retrospective case-control study was done for patients with UTI-related bacteremia due to E. 
faecalis in the Capital Region of Denmark between 2010 and 2013. Patients admitted to one tertiary 
referral hospital in the region (Rigshospitalet) were not included in the study. The Capital Region of 
Denmark has a population of 1.7 million people.  
In Denmark, the national healthcare system is tax-based and provides free access to primary care 
and public hospitals for all inhabitants. Each Danish citizen has a unique personal identification 
number, which make cross-database linkage possible for each individual. 
3.1.1 Identification of patients 
The clinical microbiological departments of Herlev and Hvidovre Hospital are providing 
microbiological services for the hospitals in the Capital Region of Denmark. Since 1997, the two 
microbiology laboratories have made records of all blood and urine culture results from samples 
from the hospitals and general practitioners in the Capital Region of Denmark. All this data is 
stored in a database. 
Information on date of sample, isolated organisms (species-level for all blood samples and some 
urine samples, genus-level for rest of the urine samples), quantity/ml of bacteria in sample (for 
urine samples) and sample-method are, among others, registered in the database.  
6 
 
3.1.2 Sample-answer Database 
I reviewed the sample-answer database from the Capital Region of Denmark from 2010-2013 to 
identify cases and controls relevant for investigating risk factors UTI-related bacteremia due to E. 
faecalis.  
For the period between January 1, 2010, and December 31, 2013, I found 700 blood cultures from 
440 different patients positive for E. faecalis. In the same period, 22.732 urine sample cultures from 
12.766 patients grew E. faecalis.  
Patients meeting the criteria listed in the two following sections were designated cases and controls 
respectively and subsequently used in the study to analyze risk factors for UTI-related bacteremia 
with E. faecalis. 
Due to reports of E. faecalis frequently contaminating urine samples, the initial focus of this study 
was to investigate if the quantity (bacteria/ml urine) of E. faecalis in a urine sample distinguished 
patients with bacteremia and a control group with E. faecalis urinary-tract infections but without 
bacteremia. However, a preliminary test of the gathered data showed no difference between the two 
patient groups. In addition, findings from other studies investigating enterococcal bacteremia and 
UTI-related bacteremia suggested that other variables might be more significant and relevant to 
investigate.  
3.1.3 CASES: UTI-related bacteremia due to E. faecalis 
I defined a case of UTI-related bacteremia due to E. faecalis bacteremia as any adult patient (>18 
years) meeting the following criteria: 
 A positive blood sample containing E. faecalis taken no later than three weeks after a 
positive urine sample for E. faecalis or Enterococcus spp. of  103–105/ml 
 Hospital admission within <30 days to the positive blood sample 
According to the Centers for Disease Control and Prevention Surgical Site Infection (SSI) 
Classification System, both superficial incisional surgical site infections (SSI) and deep incisional 
SSI occur per definition within 30 days of the operation. 28 
From the 440 patients with blood samples positive for E. faecalis, I identified 60 cases of UTI-
related bacteremia due to E. faecalis meeting the abovementioned criteria. Subsequently, I 
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examined each case manually for patient-duplicates and defective data. This reduced the 
preliminary 60 cases to 51 unique patients with UTI-related bacteremia due to E. faecalis. 
I interpreted a urine sample positive for enterococcus spp., taken from a patient in the same period 
as a blood sample growing E. faecalis, to be a urine sample of E. faecalis.  
3.1.4 Control group: E. faecalis urinary tract infections without bacteremia 
I picked patients for the control group by matching each of the 51 bacteremia-cases with two other 
adult patients (>18 years) from the 12.766 patients with a urine sample positive for E. faecalis in the 
same week as each case-patient had the positive blood sample. The criteria for the control group are 
summarized in the following bullets: 
 A urine sample positive for E. faecalis  
 No concurrent blood culture positive for enterococcal infection of the bloodstream 
 Hospital admission <30 days to the positive urine sample 
The result was a group of 102 patients: Two for each patient in the case group. For most patients, 
the closest date with patients matching the control criteria was the same date as for the matching 
bacteremia case. The date matching of patients in the case and in the control group was done to 
eliminate any possible seasonal variation or difference in urinary tract infections and blood stream 
infections. Beside the date criterion, I chose controls randomly. 
Finally, I reviewed the medical records of the 102 patients in the control group to eliminate the 
controls who did not have had any hospitalizations during the 30 days prior to the positive urine 
sample. This reduced the control group to a final of 56 patients.  
3.1.5 Hospitalization data 
Through access to medical records for each patient, I used access to information of hospital 
admission and stay, patient diagnosis and medical and surgical procedures. I reviewed both cases 
and controls for the period 30 days prior to the positive blood sample for the bacteremia cases and 
the positive urine sample for the control group, respectively.  
Each of the 51 cases and the 56 controls were evaluated for which hospital wards they were 
hospitalized to, diagnosis, catheterization, surgical procedures and demographic characteristics to 
identify potential risk factor for UTI-related bacteremia due to E. faecalis. I listed the information 
for each case and control for the following statistical analysis. 
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3.2 STUDY-DESIGN 
I chose to do a retrospective case-control study due to the data available for this study. I picked the 
case and control groups to be able to test the underlying hypothesis of the study: If the risk of 
bacteremia due to E. faecalis is increased for patients with specific demographical characteristics or 
undergoing specific procedures at the hospital. More specifically, I wanted to test if the risk of UTI-
related bacteremia due to E. faecalis is affected by modifiable variables like procedures and 
operations manipulating the urinary tract. 
The null-hypothesis tested:  
There are no differences in medical procedures or demographic characteristics between the patient 
group with UTI-related bacteremia due to E. faecalis and the patient group with E. faecalis urinary 
tract infections without bacteremia.  
Differences in the two patient groups will indicate if the risk factors investigated are found to be 
positively associated with the risk of UTI-related bacteremia due to E. faecalis. Better knowledge of 
these risk factors and the patient groups at particular risk will enable hospitals to take precautions to 
lower the risk of bacteremia.  
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Figure 1: Flowchart of selection of 51 patients with UTI-related bacteremia due to E. faecalis and 56 patients 
with UTI due to E. faecalis, without bacteremia. Data from the Capital Region of Denmark, 2010-2013.  
440 patients with ≥1 blood 
culture positive for E. faecalis 
12.766 patients with ≥1 urine 
culture positive for E. faecalis 
60 with ≥1 blood culture and 
urine culture positive for  
E. faecalis in same period 
102 with ≥1 urine culture 
positive for E. faecalis, without 
bacteremia, matched by date  
51 patients with ≥1 blood culture 
positive for E. faecalis and 
hospitalization 
56 patients with ≥1 urine culture 
positive for E. faecalis and 
hospitalization <30 days 
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3.3 STATISTICAL ANALYSIS 
To investigate risk factors for UTI-related bacteremia due to E. faecalis I did a retrospective case-
control study for patients in the Capital Region of Denmark for the years 2010-2013. 
I analyzed the data by univariate and multivariate analysis to evaluate the association between UTI-
related bacteremia due to E. faecalis and different variables that according to the literature are 
potential risk factors for UTI-related bacteremia or enterococcal bacteremia. I tested the association 
as well as statistical significance of these associations. 
After preliminary analysis of the hospitalization data and from a comprehensive literature review 
concerning UTI-related bacteremia and enterococcal bacteremia respectively, I included the 
following potential risk factors in the univariate analysis: Male sex, E. faecalis quantity of urine 
sample, catheterization, admission to urological ward, urological procedures or surgery and surgery 
overall.   
A p-value of <0.05 was considered significant and the software STATISTICA (StatSoft) used to 
calculate p-values.  
3.4 STATISTICAL TESTS 
3.4.1 Univariate test 
I calculated odds ratios and confidence intervals from contingency tables for each risk factor 
investigated and subsequently calculated the p-value according to Pearson’s chi-squared test.  
 Figure 2: Contingency table 
Exposure 
(e.g. catheterization) 
Bacteremia No bacteremia 
Yes A B 
No C D 
a = number of bacteremia cases exposed to the risk-factor investigated 
b = number of controls exposed to the risk-factor investigated 
c = number of bacteremia cases not exposed to the risk-factor investigated 
d = number of controls not exposed to the risk-factor investigated 
Odds Ratio (OR) = 
𝒂𝒅
𝒃𝒄
 
 
In this study, the odds ratio indicates the relative risk of occurrence of UTI-related bacteremia due 
to E. faecalis for patients exposed to the variable tested. 
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An odds ratio equal to one indicates that the variable investigated does not affect the risk of 
bacteremia. Odds ratios greater than one indicate that the variable is positively associated with UTI-
related bacteremia due to E. faecalis and thus potentially a risk factor. Odds ratios below one 
indicate that the variable investigated  is negatively associated with bacteremia.29 
Confidence intervals estimate the precision of the odds ratio calculated. That is, confidence 
intervals measure the precision of the odds ratio found. Small confidence intervals express a higher 
precision compared to larger confidence intervals. Confidence intervals can be used as an 
approximate estimate of statistical significance of an association between two variables even though 
the confidence intervals do not report an actual statistical significance like a p-value.  
If the 95% Confidence Interval does not cover the value 1 then the odds ratio can be interpreted as 
statistically significant. In this study, the confidence intervals of the odds ratios calculated should be 
interpreted as a proxy of the precision of the association between each variable and the risk of UTI-
related bacteremia due to E. faecalis. 
Confidence intervals (CI) of each odds ratio are found by calculating the lower and upper limits on 
the natural logarithmic scale and then take the e of the two results: 
 
 ln(CI) = ln(𝑂𝑅) ± 1.96 × √
1
𝑎
+
1
𝑏
+
1
𝑐
+
1
𝑑
 
 
Upper 95% CI = 𝑒
ln(𝑂𝑅)+1.96×√
1
𝑎
+
1
𝑏
+
1
𝑐
+
1
𝑑 
  
Lower 95% CI = 𝑒
ln(𝑂𝑅)−1.96×√
1
𝑎
+
1
𝑏
+
1
𝑐
+
1
𝑑 
 
3.4.2 Multivariate test 
Following the univariate analysis, I did a multivariate analysis by a logistic regression model to 
quantify the role of each variable on the risk of UTI-related bacteremia due to E. faecalis. I included 
the variables that in the univariate analysis were statistically significantly associated with UTI-
related bacteremia due to E. faecalis. Furthermore I excluded some of the variables to focus the 
analysis on the variables I found most likely to be causally associated with bacteremia. 
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3.5 STATISTICAL LIMITATIONS OF THIS STUDY 
The results of this study should not be interpreted as more than indicators of associations between 
the investigated variables and the risk of bacteremia due to E. faecalis. This is primarily due to the 
shortage of data quantity in terms of getting datasets and results of a satisfactory statistical power. 
Additional studies with more patients, and preferable prospective instead of retrospective, are 
needed to investigate the risk factors further. With this said, the statistical methods used in studies 
similar to this are always only investigating a mathematical likelihood of different variables having 
something to do with other variables. Even with many more patients, it is only possible to 
hypothesize about the actual causal relationships from the mathematical and statistical findings. 
Causal relationships cannot be determined from this kind of study but the statistical probability of 
associations of different variables can be analyzed. There is always a risk to miss confounding 
factors responsible for the actual association between two variables. 
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4 RESULTS 
4.1 DESCRIPTIVE & DEMOGRAPHIC 
From 2010 to 2013, 51 patients in the database from the Capital Region of Denmark met the case 
definitions and 56 patients met the definitions to be included in the control group. For a brief 
overview, I have summarized descriptive and demographic characteristics of case and control 
patients in table 1. 
 
Table 1 Descriptive and 
demographic characteristics,  
51 cases vs. 56 controls 
Characteristic 
No. of cases / 
value 
% of cases 
No. of controls / 
value 
% of 
cases 
Age, mean ± SD, years 77 (± 12.5)  68.5 (± 17.3)  
 Median of E. faecalis 
quantity in urine sample 
(range: 103 – 105 /ml) 
105/ml  105/ml  
 Male 43  84 29  52 
 Catheterization 29 57 17 30 
 Admission to urological 
ward 17 33 9 16 
 Urological surgery 10 20 3 5 
 Surgery 16 31 22 36 
 
Of the 51 patients with E. faecalis bacteremia, 43 were men corresponding to 84%. For the control 
group respectively, 29 of the 56 patients were male equaling 52%. Notably, the percentage of males 
of all 440 patients with bacteremia from E. faecalis preliminary investigated was 75%. Cases were 
averagely older than controls. The quantity of E. faecalis from the cases’ urine samples was similar 
to those of the control group in a range from 103/ml to 105/ml. Both groups samples had a median 
of 105/ml. 
Fifty-seven percent of the cases (29 patients) had an indwelling urinary catheter at a point during 
the 30-day period prior to the positive blood sample compared to 30% (17 patients) in the control 
group. About twice as many of the bacteremic patients, relatively, were admitted to urological 
hospital wards during the 30 days examined as compared to patients in the control group.  
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Ten patients (20%) in the case group had urological surgery in the previous 30-day period 
compared to only three patients (5%) in the control group. There were not any notable difference in 
the number of patients who have had surgery overall during the 30 days preceding the date of the 
positive urine samples, cases 31% vs. controls 36 %, respectively.  
I included the following variables in the univariate statistical analysis: Male, catheterization, 
admission to a urological ward, urological surgery and surgery over all.  
4.2 UNIVARIATE ANALYSIS 
I calculated odds ratios, confidence intervals and p-values (Pearson’s chi squared test) for each of 
the variables listed above to estimate associations between each one of the variables and the risk of 
UTI-related bacteremia due to E. faecalis. 
Table 2 Univariate 
analysis of risk factors 
present  for E. faecalis 
bacteremia <30 days prior 
to the positive blood or 
urine sample, 51 cases vs. 
56 controls 
Risk factors 
No. of 
cases 
(%) 
No. of 
controls 
(%) 
Odds ratio 
(95% CI) 
P-value 
Male 43  84% 29  52% 5.0 (2.0-12.5) <0.001 
Catheterization <30 days 29 57% 17 30% 3.0 (1.4-6.7) 0.006 
 Admission to urological 
ward <30 days 
17 33% 9 16% 2.6 (1.04-6.56) 0.037 
 Urological surgery <30 
days 
10 20% 3 5% 4.3 (1.1-16.7) 0.024 
 Surgery <30 days 16 31% 22 39% 0.7 (0.3-1.6) 0.39 
 
The univariate analysis showed a significant positive association of UTI-related bacteremia due to 
E. faecalis for the following risk factors: male-sex, catheterization, admission to urological ward 
and urological surgery. As opposed to this, surgery in general was negatively associated with the 
risk of bacteremia (p-value = 0.39). In other words, there was no evidence in this study of any 
association between surgery overall and UTI-related bacteremia due to E. faecalis. 
Male-sex was positively associated with the risk of UTI-related bacteremia due to E. faecalis with 
an odds ratio of five (p-value < 0.001) and the association was highly significant.  
Catheterization, admission to a urological ward and urological surgery were all also positively 
associated with bacteremia and the association was significant (for all, P <0.05). 
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According to the univariate test, male patients were significantly associated with E. faecalis UTI-
related bacteremia together with patients with catheterization, patients who were admitted to a 
urological ward or who have had urological surgery.  
4.3 MULTIVARIATE ANALYSIS 
The univariate analysis indicated that male sex, catheterization, admission to a urological ward and 
urological surgery were significantly associated with the development of UTI-related bacteremia 
due to E. faecalis. 
To learn more about the relationship between each of these variables and the risk of UTI-related 
bacteremia due to E. faecalis I used multiple regression to do a multivariate analysis of the risk 
factors positively associated with the risk of bacteremia. I did not include admission to urological 
wards in the multiple regression analysis due to the overlap of patients in urological wards and 
patients who had urological surgery. The aim of this study was to investigate the actual risk factors 
of E. faecalis bacteremia and as described earlier urological surgery have previously been 
associated with bacteremia. Thus, I found it likely that urological surgery was the actual risk factor 
and that admission to a urological ward was not. 
In the multivariate analysis, male-sex and urological surgery were found to be independent 
significant predictors of UTI-related bacteremia due to E. faecalis.  The association of 
catheterization and bacteremia, with a p-value slightly above 0.05, did not turn out to be significant 
in the multiple regression model. The results of the multivariate analysis are summarized in table 3: 
 
Table 3 Multivariate 
analysis, multiple logistic 
regression, alpha: 0.05  
Risk factors p-value 
Male 0,003 
Catheterization <30 days 0,067 
 Urological  surgery <30 days 0,044 
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5 DISCUSSION 
This retrospective case-control study indicates that male-sex, catheterization and urological surgery 
are factors that increase the risk of urinary-tract related bacteremia due to E. faecalis. Furthermore, 
male-sex and urological surgery were variables that independently of each other increased the risk 
according to the multivariate analysis. 
Several previous studies have reported enterococcus spp. as emerging pathogens responsible for 
still more cases of bacteremia 2,9,27,30. Enterococcal bacteremia is associated with both financial and 
human costs: multiple studies have reported high levels of morbidity and mortality as wells as great 
costs for the health care system 17,31. A better understanding of the factors increasing the risk of 
enterococcal bacteremia might enable the healthcare system to take appropriate precautions when 
treating patients at particular risk. 
Previous studies have investigated various risk factors for both enterococcal bacteremia and UTI-
related bacteremia. However, according to my knowledge, no previous studies have analyzed risk 
factors specifically for enterococcal UTI-related bacteremia. In addition, of the studies investigating 
enterococcal bacteremia none have done this exclusively for UTI-related bacteremia due to E. 
faecalis.  
While there is no question that enterococcus spp. is a source of both disease and death, no previous 
studies have evaluated the epidemiology of E. faecalis UTI-related bacteremia. Infections of the 
urinary tract are a frequent point of infection for enterococcal bacteremia according to several 
studies. Moreover, genitourinary infections are specifically associated with bacteremia due to E. 
faecalis and thus it is relevant to investigate the risk factors associated with UTI-related bacteremia 
due to E. faecalis. Graninger & Ragette previously identified predictors for UTI-related bacteremia 
to include, among others, indwelling urethral catheters, obstructive urological diseases, male sex, 
immunosuppressant therapy, cigarette use within 5 years, diabetes mellitus for patients older than 
70 and prior antibiotic treatment. 17,32,33 
This study supports some of the risk factors for enterococcal bacteremia found in these previous 
studies and extends the prior work by investigating surgery overall, male-sex, catheterization and 
urologic surgical procedures as risk factors specifically for UTI-related bacteremia due to E. 
faecalis. Additional studies investigating both E. faecalis and E. faecium are necessary to detect 
differences in the association of different risk factors and bacteremia for the two species.  
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Since antibiotic resistance is more prevalent for E. faecium there is good reason to distinguish 
between bacteremia from E. faecium and E. faecalis in order to apply efficient antimicrobial therapy 
in relation to efficacy and to lower the risk of further development and spread of antibiotic 
resistance. 
With a p-value below 0.001, my finding that the risk of UTI-related bacteremia due to E. faecalis 
was greater for men than for women was highly statistically significant. This might offhand seem 
questionable because urinary tract infections in general are much more common in women 
compared to men 34.  
Previous studies have evaluated different gender distributions for enterococcal bacteremia, mainly 
with a male majority. In a study by Anderson et al., investigating risk factors for infective 
endocarditis in patients with enterococcal bacteremia, there were a total of 61 (49%) male patients 
and 64 (51%) female patients in the case and control group combined.35 In correlation with the 
findings of this study, Pinholt et al., 2013, reported 69.4%, 69.4% and 76% male patients of E. 
faecalis bacteremia in community acquired, hospital acquired and healthcare associated cases 
respectively in the North Denmark Region and the Capital Region of Denmark from 2006-2009 2. 
Other studies have reported males to count for 58%27, 61%36, 60% 37, 53%38, 66%39,  55%40, 48%41 
and 61% and 68% with and without high level gentamicin resistance respectively3 of enterococcal 
bacteremia cases. In addition, previous studies of UTI-related bacteremia showed a slight 
overweight of males;  55.3% 42 and 55% 40.  
Overall, my findings together with the previous studies evaluating gender distribution of UTI-
related bacteremia and enterococcal bacteremia show that a majority of men had enterococcal 
bacteremia. The preliminary dataset analyzed in this study showed that the male-dominance in 
enterococcal bacteremia overall is larger for E. faecalis with 75% males compared to E. faecium 
with 60% males. Thus, men might be at an overall greater risk of UTI-related bacteremia due to E. 
faecalis compared to bacteremia from other enterococcus species and other UTI-related bacteremia 
in general.17 I did not find any studies evaluating gender ratios among UTI-related bacteremia due 
to Escherichia coli or other bacteria. 
Gender-specific differences in the risk for bacteremia can be used to take appropriate precautions 
when treating or operating male patients. By taking into account, the level of risk estimated for the 
individual patient, the hospital can chose appropriate antibiotic prophylaxis before urological 
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surgery or catheterization. My findings indicate that strategies to prevent E. faecalis bacteremia 
related to urinary tract infections should be gender-specific. 
I did not have access to data showing the gender ratios at the urological wards in the Capital Region 
of Denmark. That information would have been useful in order to investigate if the majority of 
males with UTI-related bacteremia due to E. faecalis found in this study was simply representing 
the overall gender distribution of patients undergoing manipulation of the urinary tract through e.g. 
catheterization or urological surgery.  
5.1 CATHETERIZATION 
According to the univariate analysis, urethral catheterization was positively associated with the risk 
of UTI-related bacteremia due to E. faecalis. Notably, the univariate analysis found the number of 
patients with urinary catheters in the case and the control group to be significantly different. 
According to the multivariate analysis, there was no independent effect of catheterization on the 
risk of UTI-related bacteremia due to E. faecalis. However, several other studies examining the 
effect of urinary catheters on enterococcal bacteremia or UTI-related bacteremia found a significant 
association, which support the positive association I found in the univariate analysis. 14,15,38,43 
The positive association of urinary catheterization and bacteremia is most likely a result of a 
disruption of the urothelium exposing the blood stream for bacteria from the urinary tract. Jerkeman 
& Braconier, 1992, found that urinary catheters were more common in a bacteremic patient group 
compared to a non-bacteremic group.40 In one study examining exogenous risk factors for 
enterococcal bacteremia, 58% of the patients had a urinary catheter compared to 31% in the control 
group.27 Urinary catheters were independently associated with enterococcal bacteremia in a logistic 
regression model in that study, which in addition found that 81% of enterococcal bacteremia was 
due to E. faecalis.27 Maki & Agger, analyzing 153 patients with enterococcal bacteremia 
retrospectively, found similar results with 76% of the patients in the case group with either urinary 
catheter or intravascular catheter.16 Another study showed that more than 80% of patients with 
enterococcal bacteremia had intravascular catheters and 60% had urinary catheters44. Three 
different studies between 1989 and 2013 also reported catheterization as a risk factor associated 
with enterococcal bacteremia. 2,37,41   
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5.2 UROLOGICAL SURGERY  
Similar to catheterization, urological surgery entails a risk to disrupt the urothelium and expose the 
blood stream for bacteria, setting the patient at risk for bacteremia. 
In this study, 20% of the patients with UTI-related bacteremia have had urological surgery within 
30 days prior to the positive blood sample. This makes the association of urological surgery and 
bacteremia independently significant. Notably, the data from the patients examined did not show 
any association between surgery overall and UTI-related bacteremia due to E. faecalis. In support of 
my findings, Caballero-Granado et al.  did not find surgical treatment of all locations to be a risk 
factor for enterococcal bacteremia. 27 
This indicates that the risk for UTI-related bacteremia due to E. faecalis was affected by urological 
surgery specifically and that the explanation for this might be that the barriers, which normally 
protect the blood stream from bacterial infections, were disrupted. Enterococci are common 
commensal members of the human gut and frequently pollute the urinary tract. Thus, a disruption of 
the urothelium will often pose a risk of bacteremia due to the frequent enterococcal pollutions of the 
area. 
Previous studies have also examined surgical treatment and urological treatment specifically as a 
risk factor for bacteremia. Patients diagnosed with enterococcal, staphylococcal, Streptococcus 
bovis and streptococcal infective endocarditis during a 10-year period were retrospectively 
evaluated by Mohee et al., who found that urological surgery was associated with enterococcal 
infective endocarditis with a p-value below 0.05.45 In another previous study, postoperative 
bacteremia was associated with urological procedures and notably with the urinary tract reported as 
the dominating source of the bacteremia. 46  
Overall, this study shows an increased risk of UTI-related bacteremia due to E. faecalis for patients 
with prior (<30 days) manipulation of the urinary tract. This is supported by several other 
studies.27,46 
5.3 ANTIBIOTIC PROPHYLAXIS TO PREVENT BACTEREMIA 
As described earlier, enterococcal bacteremia is associated with high rates of morbidity and 
mortality. Beside the ultimate human costs of bacteremia, the economic costs for the health care 
systems are also comprehensive. In my study, it would have been relevant to examine the effect of 
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antibiotic treatment prior to the positive blood and urine samples. However, since the 
microbiological data available did not contain isolate information, I could not retrieve information 
on antibiotic susceptibility for the strain for each case. Thus, the actual effect of the antibiotics 
administered would be pure conjecture. Details on the antibiotic treatment of each patient would not 
give an accurate impression of the actual effect of the treatment.   
Due to both intrinsic and acquired resistance of enterococcus spp., antimicrobial treatment is often 
complicated. In the case of preventing bacteremia following manipulation of the urinary tract, a 
urine culture prior to catheterization or urological operation could reveal infections of the urinary 
tract. Subsequently, the treating physicians could then initiate appropriate antibiotic prophylaxis 
based on typing of the bacteria and identification of resistance-patterns. 
Antibiotic treatment of E. faecalis is usually for treating infective endocarditis. Thus, there is 
limited experience from antibiotic treatment of bacteremia due to E. faecalis not associated with 
infective endocarditis. As described earlier, enterococci are resistant to cephalosporins, 
aminoglycosides and clindamycin agents, which complicate antibiotic treatment of enterococcal 
infections. In addition, the clinical importance of enterococci is not always evident when 
enterococci are isolated together with multiple other bacteria 14.  Collectively, this complicates 
antimicrobial prophylaxis for enterococcal bacteremia. 
In the two urological wards in the Capital Region of Denmark, it is mandatory to take a pre-
operative urine sample from patients undergoing extracorporeal shock wave lithotripsy, endoscopy 
of the urinary tract or surgery of the kidney. Several studies have confirmed the association of 
enterococcal urinary tract infections with bacteremia. However, the Danish guidelines for 
antimicrobial prophylaxis prior to urological procedures like extracorporeal shock wave lithotripsy, 
transurethral procedures, prostate biopsies and insertion of catheters does not cover enterococci. 
The guidelines advise for the use of Gentamicin and Ciprofloxacin for prophylaxis, but E. faecalis 
is frequently resistant towards these antibiotics.23,47  
Previous studies evaluating the effect of antimicrobial prophylaxis before urological procedures 
have used gentamicin 45 which is problematic in relation to enterococcus spp. due to the widespread 
resistance. High-level gentamicin resistance (HLGR) isolates of E. faecalis was reported to 
constitute 27% in Denmark in 2012 and 62% of E. faecium isolates. Overall, antibiotic resistance is 
more widespread for E. faecium compared to E. faecalis and this trend seems to have been 
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increasing over some years.48–50 For enterococcal bacteremia, appropriate antimicrobial therapy is 
reported to be essential to reduce mortality.37  
As early as 1982, Eykyn advised that patients with infected urine who required a urological 
procedure should be treated prophylactic with an antibiotic to which the urinary bacteria are 
sensitive.46 Antibacterial treatment is associated with a reduced risk of bacteremia.17 A single-dose 
of antimicrobial prophylaxis has been shown to be effective to prevent infections related to 
urological surgery.51 Another important aspect of using antibiotics is that inappropriate use bears 
the risk to prompt development and spread of antibiotic resistance.27 All this call for individualized 
antibiotic prophylaxis based on urine samples prior to manipulation of the urinary tract. 
Individual antibiotic prophylaxis against enterococci might be beneficial in terms of both patient 
safety and costs for the hospital. Treatment of bacteremia and in particular infective endocarditis is 
comprehensive in terms of both time and money. If individual prophylactic treatment can prevent a 
few cases of infective endocarditis, it may very well pay itself off economically.   
Trials with a randomized controlled study-design are necessary to assess the efficacy of individual 
antimicrobial prophylaxis prior to urological procedures to prevent enterococcal bacteremia. 
5.4 LIMITATIONS OF THE STUDY 
My study has some limitations and thus my findings should be considered in the context of these.  
First, the retrospective study-design gives rise to some uncertainty regarding the identified cases. I 
did not have information on the focus of infection for the cases of bacteremia. A prospective study 
is a more robust study design, which could have enabled a contemporary examination of each 
patient by medical staff. However, a prospective study was not possible due to the low incidence of 
UTI-related bacteremia due to E. faecalis in the few months this study was done. 
Second, I did not have access to the necessary antimicrobial resistance patterns or molecular typing 
methods to confirm that the E. faecalis isolates from the blood and urine were identical for each of 
the patients in the case group. Thus, I am not certain that the bacteremia cases reflected a primary 
urinary tract infection. However, the convergent E. faecalis infection of both blood stream and 
urinary tract make the association plausible.  
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Third, I did not evaluate the antibiotics administered to the patients in the two groups. This 
however, would only have been useful if I had information on the resistance patterns of the strains 
isolated from each patient.  
Fourth, the statistical strength of this study is low due to the size of the patient groups evaluated and 
thus my findings might be limited. Larger studies are necessary to confirm or disconfirm my results. 
The low number of cases and controls risk hiding important results and making mistaken 
conclusions. 
Fifth, the data in this study come partly from an automatic retrieval from a regional database and 
subsequently I reviewed the medical records manually for each patient. There is a risk that the data 
obtained on the presence of urinary catheters from both the database and the medical records is not 
reliable. This could be a confounding factor and thus have impact on the results.  
Sixth, I chose the patients for my control group from date-criteria solely. It had been preferable to 
do a more comprehensive matching of controls to cases regarding demographic and clinical 
characteristics according to case-cohort methodology. 
Seventh, previous studies investigating enterococcal bacteremia have focused on nosocomial 
infections. This is probably reasonable because the majority of enterococcal bacteremia are 
nosocomial 2,52. However, it is not evident how to distinguish nosocomial bacteremia from 
community-acquired satisfactorily because the origin of the blood stream infection might happen 
weeks before the bacteremia is detected.  
Finally, there are other risk factors previously identified for enterococcal bacteremia and UTI-
related bacteremia. To get the full picture of the risk factors for UTI-related bacteremia due to E. 
faecalis additional and larger studies are necessary. To illuminate the interactions of the different 
risk factors they must all be evaluated in the same study. Furthermore, other enterococcus species 
should also be included, in particular E. faecium, to analyze similarities and differences between the 
two predominant species’. 
This study does not show anything about the causal relationship between UTI-related bacteremia 
due to E. faecalis and the risk factors investigated. My findings imply associations between the risk 
factors and UTI-related bacteremia due to E. Faecalis. A number of confounding factors might be 
involved in the overall picture. However, due to several previous studies with similar findings I find 
my results plausible.  
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The increased risk for UTI-related bacteremia due to E. faecalis for catheterized patients and 
patients undergoing urological surgery suggests that precautions could lower the incidence. Specific 
patient subgroups can be tested for enterococcal urinary tract infections prior to manipulation of the 
urinary tract and consequently appropriate antibiotic treatment can be initiated. Hospital physicians 
should be extra careful when dealing with male patients. 
6 CONCLUSION 
In conclusion, I found male sex, urological surgery and catheterization to be associated with UTI-
related bacteremia due to E. faecalis. In addition, my study shows that the quantity of E. faecalis in 
urine samples is not a predictor of bacteremia. Thus, the risk of bacteremia is probably due to a 
presence of E. faecalis in the urinary tract coinciding with a disruption of the urothelium and not 
affected by the quantity (105-103/ml) of E. faecalis in the urinary tract. 
Bacteremia is a serious problem in hospitals and individual antimicrobial prophylaxis for specific 
patient subgroups at risk might be a way to reduce this problem. Appropriate antibiotic treatment 
following a urine sample to identify a possible urinary tract infection can ideally enhance the safety 
of patients at risk of bacteremia due to E. faecalis. 
This study show that men undergoing urological surgery, and to a lesser extent catheterization, are 
at particular risk for UTI-related due to E. faecalis. As discussed, changes in the guidelines for 
antibiotic prophylaxis at the urological wards in the Capital Region of Denmark might be one way 
to reduce the number of UTI-related bacteremia cases due to E. faecalis.   
Despite the limitations listed earlier, I believe that the findings in this study highlight the 
importance of individual tailoring and antibiotic treatment of patients undergoing manipulation of 
the urinary tract by either surgery or catheterization. 
7 PERSPECTIVES 
In relation to this study, I did a comprehensive literature review of enterococcal bacteremia and 
UTI-related bacteremia. One thing, which I found astounding, was the lack of studies investigating 
risk factors specifically for each of the bacterial species’ most frequently causing UTI-related 
bacteremia. 
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Studies evaluating risk factors for the most dominating bacteria species’ causing UTI-related 
bacteremia might elucidate important differences in the epidemiology, etiology and virulence of 
these species. Since it is possible to take pre-operative urinary samples and identify the bacteria in a 
potential urinary tract infection, a better understanding of the different species frequently causing 
UTIs might facilitate better prophylactic treatment for UTI-related bacteremia. This might very well 
save money and reduce morbidity and mortality as well as lower the risk of further development 
and spread of antibiotic resistance.  
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